Commercial insight into the pharma and biotech sector.

What is EvaluatePharma®?
A unique source of insight into the past and future commercial performance of the pharmaceuticals and biotechnology sector, delivered in a user-friendly online subscription service.
Who uses it?
EvaluatePharma® is relied on by leading executives in the Pharmaceutical and Biotech industry, as well as the world's leading Investment Banks and Management Consultancies.

Our clients can be found in business and commercial analysis, business development, competitive intelligence, corporate planning, forecasting, licensing, M&A, market analysis, marketing, new product planning, strategic planning and many other departments of pharma companies.

Top of page

Why do they use EvaluatePharma®?
EvaluatePharma® delivers unique insight into the pharma sector, identifying and explaining market events that change the market valuations of companies, portfolios, individual products, therapy areas, and technologies.

From benchmarking product launches to identifying acquisition targets, from finding licensing partners to making investment choices, EvaluatePharma® helps our clients to make better business decisions.

Top of page

Why do they trust EvaluatePharma®?
Our team of experienced Analysts have developed a comprehensive suite of company models and forecasts, the core of EvaluatePharma®, to include an unparalleled breadth and depth of content.

The team employs a rigorous methodology to collate, organize and deliver the most-up-to-date commercial performance data via the EvaluatePharma® service.

Top of page

What is in EvaluatePharma®?
  • historic sales data drawn from the most complete and reliable source of industry data - the reporting companies themselves
  • product consensus forecasts to 2012, compiled from reports published by leading equity analysts, now with a dynamic archive of forecasts allowing you to follow forecast trends
  • in-depth company financial information, including forecasts to 2012

Top of page

Where does the data come from?
EvaluatePharma®'s experienced team of industry analysts continuously update industry data, including all reported financial and sales data, from SEC filings, annual and quarterly reports, presentations to analysts and investors, company press releases, supplemented with information from additional sources, notably the FDA and US PTO websites as a source of patent information. Consensus forecasts for marketed and emerging products are compiled from the latest research reports from leading equity analysts.

Top of page

How often is the data updated?
  • Press Releases are classified and added daily, typically within 24-48 hours of publication.
  • Company quarterly sales are updated as reported, and are added to the site within 24 hrs of publication.
  • All other data, including forecasts, are gathered and updated on a daily basis as available and added to site comprehensively at least once per month.

Top of page

Where to next?

If you didn't find the answer to your question, contact us for more information
About You - find out how our data benefits our customers
Read some sample reports

 

Subscriptions

EvaluatePharma® delivers unique commercial insight into the past and future performance of the pharma and biotech sector, in a user-friendly online subscription service.

Sign-up Now!